Suggestions
Joe Schachle
Chief Operating Officer at Ocuphire Pharma
Joseph K. Schachle is the Chief Operating Officer at Ocuphire Pharma, a clinical-stage ophthalmic biopharmaceutical company. He was appointed to this position on November 27, 2023, as part of a strategic initiative to enhance the company's leadership team in preparation for advancing its lead product, APX3330, through registrational studies.134
Professional Background
With over 30 years of experience in the biotech and pharmaceutical industries, Schachle has held various senior roles across multiple functional areas, including operations, sales, and marketing. Before joining Ocuphire, he served as the COO at Opus Genetics, where he oversaw corporate functions such as human resources, finance, and commercial operations. His previous experience includes significant roles at Grifols, Parion Sciences, and Inspire Pharmaceuticals, where he was involved in marketing and operational integration during acquisitions.123
Education
Schachle holds an MBA from Old Dominion University and a BBA in Marketing from James Madison University, both located in Virginia.1
Current Role
In his role at Ocuphire, Schachle is expected to leverage his extensive experience to drive the company's growth and operational efficiency, particularly as it focuses on developing therapies for diabetic retinopathy, a condition affecting millions of people with diabetes.14
